Alx Oncology Holdings Inc

+0.95 (+1.76%)
Mergers / Acquisitions

ALX Oncology Strengthens Immuno-Oncology Pipeline With Acquisition Of ScalmiBio

Published: 10/07/2021 11:54 GMT
Alx Oncology Holdings Inc (ALXO) - Alx Oncology Strengthens Immuno-oncology Pipeline With Acquisition of Scalmibio.
Alx Oncology - Alx Oncology Made Initial Payment to Stockholders of Scalmibio at Closing on October 4, 2021 of Approximately $4.5 Million in Cash.
Alx Oncology Holdings Inc - Alx Oncology Has Agreed to Pay Certain Milestones Based on Clinical Development of Acquired Scalmibio Technology.
Alx Oncology - Agreed to Pay a Low Single Digit Royalty on Net Sales of Any Products Developed From Scalmibio Acquired Technology for a Defined Term.